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Leukocyte migration in immune complex glomerulonephritis: Role of
adhesion receptors. The application of our evolving knowledge of adhe-
sion receptors to experimental models of immune complex glomerulone-
phritis has led to substantial advances in our understanding of how
leukocytes emigrate from the vasculature into glomeruli and produce
glomerular dysfunction. With respect to neutrophil (PMN) migration and
activation in the context of nephritis, the adhesion molecules 0M132, alibi33,
and intercellular adhesion molecule-i (ICAM-1) seem to be most essen-
tial, with more modest (and less well defined) contributions by P-selectin,
a431, and vascular cell adhesion molecule-i (VCAM-1). The influx of
PMNs is driven largely by complement and a chemokines. In contrast to
PMNs, monocyte/macrophage migration and activation during nephritis
appear to be largely mediated by the adhesion molecules aLl3z, a4f31,
ICAM-1, VCAM-1, and potentially P-selectin. Monocyte/macrophage
migration also differs from that of PMNs in that it is complement-
independent and involves 13 chemokines. Further refinement of our
understanding of the role of adhesion receptors in immune glomerulone-
phritis may eventually lead to clinically applicable strategies to ameliorate
glomerular inflammation and resulting glomerulosclerosis.
Leukocyte emigration from the vasculature into an inflamma-
tory focus is most easily considered using the general paradigm in
which leukocyte rolling is followed by endothelial adhesion and
transendothelial migration. A panoply of adhesion receptors
mediate these processes [reviewed in 1—3]. In general, leukocyte
rolling is mediated by selectins and their carbohydrate counterre-
ceptors while endothelial adhesion and transendothelial migra-
tion are mediated by integrins and their immunoglobulin super-
family counterreceptors. The overall driving force for this process
is the local generation of cytokines and chemoattractants [1, 2].
The selective recruitment of leukocytes into tissue is achieved
through various combinations of adhesion receptors, cytokines
and chemokines. In addition to their role in leukocyte migration,
adhesion receptors may mediate leukocyte function within the
inflammatory site, participating in activation processes such as
cytokine production, phagocytosis, and the respiratory burst [3].
Over the past several years, numerous studies have implicated
various adhesion receptors in the pathogenesis of immune com-
plex glomerulonephritis, most notably in the processes of leuko-
cyte migration and in situ activation. Most studies to date have
focused on experimental models of glomerular inflammation,
principally anti-glomerular basement membrane (GBM) nephri-
tis. This model is characterized by antibody deposition in the
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GBM, local complement activation, and an infiltrative/diffuse
proliferative nephritis [reviewed in 4]. The acute leukocyte infil-
trate consists largely of neutrophils (PMNs) and is followed by the
chronic influx of monocytes/macrophages (M4s). Leukocyte in-
flux into glomeruli is critical to the local tissue damage that occurs
in this model (as manifested by proteinuria), the accompanying
glomerular metabolic alterations (such as increased eicosanoid
production), as well as the development of glomerulosclerosis
[5—8].
An additional model of importance for the study of glomeru-
lonephritis has been the use of murine lupus models. Murine
lupus is also characterized by the deposition of immune com-
plexes within the glomerulus, local complement activation, and a
glomerular inflammatory infiltrate that ultimately produces gb-
merulosclerosis [9]. Unlike anti-GBM nephritis, however, there is
no clear acute or chronic inflammatory phase in the evolution of
disease.
In this review, we will consider the extant data on the role of
adhesion molecules in immune-mediated glomerubonephritis, fo-
cusing principally on data derived from the aforementioned
experimental models. Because PMN and monocyte/M4 migration
proceed independently in the context of immune-mediated gb-
merulonephritis [6, 7], we will consider the role of adhesion
molecules in these processes separately.
PMN migration in glomerulonephritis
Role of selectins
Data on the role of selectins in the migration of PMNs into
glomeruli in immune mediated gbomerulonephritis are relatively
meager. With respect to E-selectin (CD62E), gbomerular expres-
sion is acutely up-regulated in anti-GBM nephritis; however,
antibodies against E-selectin have little effect on the influx of
PMNs into the glomerulus or their in situ activation as assessed by
proteinuria (Table 1) [10].
The role of P-selectin (CD62P) in gbomerubonephritis is at
present uncertain (Table 1). In one recent study on anti-GBM
nephritis in mice, P-selectin was found to be rapidly expressed on
gbomerular endothelium immediately prior to the influx of PMNs,
and an anti-P-selectin antibody largely inhibited the influx of
PMNs and the accompanying proteinuria [11]. None of the
gbomerular expression of P-selectin in this study appeared to be
platelet-derived as platelet depletion did not affect the up-
regulation in gbomerular P-selectin during disease [11]. These data
contrast with recent studies of anti-GBM nephritis in P-selectin
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E selectin aGBM (rat) 'fl', ? ab [101
P selectin aGBM (mouse) 'fl', cndo. ab 'U' 'U' [11]
aGBM (mouse) knock-out 'fl' 'if [121
IC (rat) 3 ab [13]
aGBM (rat) ab [14]
0M aGBM (rat) ab 4J' 'lJ' [101
aGBM (rat) 'if, PMN ab or 'U' [20]
0L aGBM (rat) sI. 'if, PMN [19]
aGBM (rat) ab '' [10]
132 aGBM (rat) 'if, PMN [19]
oGBM (rat) ab 'U' 'I)' [10,21]
aGBM (rabbit) ab [22, 231
ICAM-1 aGBM (rat) 'if, endo./mes. [19]
lupus (mouse) 'if, mcs. [28]
aGBM (rat) 'if, ? ab 'U' 'U [10)
aGBM (rabbit) ab [23]
/3 aGBM (rat) 'if, platelets recpt. block. 'U' [14]
aGBM (rat) defib. 'U' 4J' [14]
04 aGBM (rat) ab 'U' 'U' [10]
aGBM (rat) ab 'U, <> [21]
VCAM-1 aGBM (rat) 'if, endo./mes. [10]
lupus (mouse) 'if, mes. [36]
Symbols are: 'if, increase; 'U' decrease; , no change; ?, uncertain.
Abbreviations are: aGBM, anti-GBM nephritis; IC, immune complex nephritis; endo., endothelium; mes., mesangial; ab, antibody; sI., slight; recpt.
block., receptor blockade; defib., defibrination.
deficient mice [121. In these mice, PMN recruitment and protein-
uria were both increased in context of anti-GBM nephritis relative
to P-selectin sufficient mice. Two studies in nephritis in rat also
observed that a function blocking anti-P-selectin antibody had
little effect on PMN influx and proteinuria [13, 141.
It is unlikely that these discrepancies simply reflect species
differences in the role of P-selectin in that diametrically opposite
results were obtained in the same species (that is, mice). The lack
of concordance regarding the role of P-selectin in nephritis,
however, may reflect its potentially complex role in inflammation.
In addition to mediating PMN adherence to endothelium, P
selectin may also regulate PMN-platelet interactions and the
consequent generation of lipoxins [12, 13]. These lipid mediators
may be negative regulators of PMN migration and activation, it is
also worth noting that anti-GBM nephritis in mice, unlike that in
rat or rabbit, is complement- and platelet-independent [11].
There are no current in vivo studies addressing the role of
L-selectin (CD62L) in mediating PMN migration during anti-
GBM nephritis. However, L-selectin does appear to play a role in
the adherence of PMNs to glomerular endothelium in vitro, and
the ligand for L-selectin is induced by cytokine activation of
glomerular endothelium [15]. Given data suggesting a role for
L-selectin in mediating leukocyte influx into other inflamed
tissues, further investigation may well substantiate a role for this
selectin in the PMN phase of anti-GBM nephritis.
The paucity of data on the role of selectins in anti-GBM
nephritis may reflect their relative lack of importance to this
model of inflammation. In general, selectins mediate rolling under
conditions of blood flow, whereas in more static conditions,
adherence via 132 integrins takes precedence. Since intracapillary
thrombosis or coagulation can be a feature of glomerulonephritis
[16], selectin-mediated rolling may be of limited importance in
regulating the influx of leukocytes into the glomerulus during
inflammation. It is also possible that the selectins may act in
concert and that inhibition of multiple selectins is necessary to
produce an effect on PMN emigration into glomeruli [17].
Role of 132 integnns
The most important mechanism driving PMN influx into gb-
meruli in the context of immune-mediated glomerulonephritis
appears to be /32 integrin interaction with members of the
intercellular adhesion molecule (ICAM) family, a conclusion
derived from a combination of in vitro and in vivo data. In vitro,
both anti-/32 integrin and anti-ICAM-1 antibodies substantially
disrupt PMN adhesion to glomerular mesangial cells or endothe-
hum [15, 18]. Although most of this interaction is 132 integrin-
dependent, there may be variations in the roles of specific /32
integrins dependent upon the state of activation of the glomerular
cell. Overall, both 01/32 (CD1Ia/CD18, LFA-1) and 0M132
(CD11b/CD18 or Mac-i) appear to be most important to the
interaction of PMNs and glomerular mesangial cells [18). The role
of ICAM-1 (CD54) varies more substantially with the state of
activation of the glomerular cell. Whereas most of the adhesion of
PMNs to cytokine activated-glomerular cells is ICAM-1 depen-
dant, virtually all of the adhesion in the absence of cytokine
stimulation is ICAM-1 -independent [18].
Data on anti-GBM nephritis in rat corroborate the importance
of 132 integrins and ICAM-1 to PMN migration in vivo (Table 1).
First, ICAM-i is up-regulated during glomerular inflammation,
both on glomerular capillary endothelium as well as within the
mesangium [19]. Second, in the acute phase of anti-GBM nephri-
tis, both anti-/32 integrin and anti-ICAM-1 antibodies attenuate
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PMN influx [10, 20, 21]. In vivo, aM/32 appears to the most
important with respect to PMN emigration and proteinuria with
little contribution by aLI32. Whether or not a132 (CD1Ic/CD18 or
p150/95) is important is unclear. Although anti-/32 integrin anti-
bodies inhibit PMN influx, they do not abolish it. In the afore-
mentioned studies, approximately one third of PMN migration
persists despite effective 132 integrin inhibition [10, 20, 21]. Thus,
there appear to be important P2 integrin-independent pathways
for PMN migration into glomeruli, potentially mediated by 13 and
133 integrins (see below). Moreover, anti-ICAM-1 antibody atten-
uates the influx of PMNs into inflamed glomeruli less substantially
than antibody to 132 integrins, suggesting a role for alternative
ligands for P2 integrins (see also below).
The available data on the role of 132 integrins and ICAM-1 in
anti-GBM nephritis in the rabbit stand in contrast to the afore-
mentioned studies on anti-GBM nephritis in the rat (Table 1). In
the two available studies to date in rabbits, two different anti-/32-
integrin antibodies and an anti-ICAM-I antibody all failed to
inhibit PMN migration following disease induction [22, 23]. The
discrepancy between the studies in rat and rabbit suggest that
there may be important species differences in the contribution of
132 integrins and ICAM-1 to acute glomerular inflammation, and
corroborate the potential importance of 132 integrin-independent
pathways of PMN migration/activation (a component of which is
nonetheless observable in the rat as noted above).
Although P2 integrins probably contribute to PMN trafficking
into inflamed glomeruli, it is not necessarily true that the benefi-
cial effects of anti-p2 integrin monoclonal antibodies are strictly
mediated via their effects on PMN emigration. A protective effect
of anti-aM antibody therapy in the acute phase of anti-GBM
nephritis (in terms of proteinuria) has been noted in the absence
of an effect on PMN emigration [20]. It was concomitantly
observed that PMNs within inflamed glomeruli exhibit up-regu-
lated surface aM confirming their activated state in situ [20]. A
similar dissociation of anti-p2 integrin therapy on PMN emigra-
tion and activation has been previously observed in other models
of inflammation [24, 25]. These observations suggest that PMN
emigration and activation are separable phenomena, though both
processes are largely mediated through aMP2.
Apropos to this issue, studies suggest that 132 integrins may also
be important for the generation of lipid mediators (such as
leukotriene B4) by PMNs in response to immune complexes [26].
The contribution of P2 integrins to leukotriene B4 production in
response to immune complexes is independent of their role in
adhesion [26]. Notably, leukotriene B4 production is markedly
up-regulated in nephritic glomeruli as a function of the influx of
PMNs and may contribute to the chemotactic activity generated
within glomeruli [271.
The importance of ICAM-I to the influx of PMNs raises the
issue of the regulation of this adhesion molecule within the
glomerulus in the context of inflammation. ICAM-1 is expressed
constitutively (albeit weakly) by glomerular mesangial cells in vitro
and is dramatically up-regulated in vitro by cytokines [such as
tumor necrosis factor (TNF)-a, interleukin (IL)-1/3] [18]. In
murine lupus, low level constitutive expression is seen in normal
kidneys with marked up-regulation observed in the context of
glomerular inflammation paralleling an increase in TNF-a and
IL-1f3 expression [28]. In anti-GBM nephritis, TNF-a and IL-ip
are co-expressed by glomeruli in the acute phase of the disease
concomitant with the up-regulation of ICAM-1 [10, 291. Addition-
ally, studies using IL-I receptor antagonist, anti-TNF antibody
and soluble TNF receptors in this model suggest that both
mediators participate in the influx of PMNs [10, 30]. Most likely
the sources of these cytokines are the resident and infiltrating
leukocytes within the kidney, although mesangial cells can also
potentially contribute to their production [31, 32].
Regarding the role of ICAM-1 as a ligand for 132 integrins, it is
noteworthy that the kinetics of ICAM-1 up-regulation are some-
what slower than the time course for PMN influx. PMN influx
peaks rapidly (within I to 3 hr) whereas ICAM-i expression does
not appear to up-regulate substantially before four to six hours
[18, 27]. This discrepancy, and the aforementioned difference
between the efficacy of anti-ICAM-1 and anti-p2 monoclonal
antibodies in disrupting adhesion in vitro or blocking PMN
emigration in vivo, suggest that PMNs may enter glomeruli in a 132
integrin-dependent/ICAM-1 -independent fashion. One possibility
is that 132 integrins may interact with ICAM-2 (CD1O2), a related
membrane of the immunoglobulin gene superfamily that is ex-
pressed constitutively on glomerular capillary endothelium [33].
This hypothesis remains to be directly tested.
Role of /3 integrins
Although a 132 integrin/ICAM-1 interaction appears to be a
major mechanism for PMN emigration into inflamed glomeruli, it
is clearly not the only interaction regulating this process as noted
above. One potential alternative pathway for PMN emigration
into inflamed glomeruli was suggested by recent studies that
demonstrated that platelets are essential for the efficient influx of
PMNs into the glomerulus in the acute phase of anti-GBM
nephritis in rat [14, 31. Conversely, it was also observed that
PMNs serve to import platelets into the inflamed glomerulus. The
co-migration of PMNs and platelets into the glomerulus was
partially fibrinogen-dependent, in that defibrination attenuated
PMN and platelet co-migration into glomeruli in anti-GBM
nephritis, but apparently P-selectin-independent [14]. Thus, this
interaction appeared to be largely mediated by other molecular
mechanisms that remain to be elucidated.
One consequence of this observed PMN-platelet interaction
was that (3 integrin (CD6I) expression within glomeruli was
markedly up-regulated (Table 1) [14]. This marked increase in f3
integrin expression resulted principally from the expression of the
fibrinogen receptor, a!lhPl (CD41/CD61), by platelets carried into
the glomerulus via their interaction with PMNs. Using defibrina-
tion and a specific receptor blocker of alIhP3 in vivo and in vitro,
it was observed that the co-activation of platelets and PMNs via
fibrinogen/aJ1f33 appeared to play an important role in the
glomerular dysfunction (in terms of proteinuria) which occurred
acutely in anti-GBM nephritis (Table 1).
Role of 13 integrins
Although it was previously thought that PMNs did not express
a4f31 (VLA-4, CD49d/CD29), more recent work has established
the expression of low levels of this integrin on circulating PMNs
[351. This study also demonstrated that a4131 expressed by PMNs
plays a functional role in the migration of these cells in inflam-
mation, although its relative contribution appears to vary as a
function of the tissue involved and inflammatory stimulus [35].
With respect to these observations, it has been observed that a
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M4 influx Proteinuria Reference
P selectin aGBM (rat) 'U' endo. ab 'U' 'U' [411
0M aGBM (rat) ab [201
0L csGBM (rat) 'U' M4 [191
sGBM (rat) 'U' M4IT cells ab+anti-ICAM-1 ab 'U' 'U, [431
rGBM (rat) 'U', M4/NK cells ab 'U, 'U, [421
/32 aGBM (rat) 'U', M4 [191
csGBM (rat) ab 't' ' [21]'
csGBM (rat) ab+anti-cr4 ab <' 'U, [21]
ICAM-1 aGBM (rat) 'U', endo. ab+anti-csL ab 'U' 'U' [43]
sGBM (rat) 'U', endo. ab 'U, 'U, [421
lupus (mouse) 'U' mes. [28]
04 aGBM (rat) ab <> < [21]
aGBM (rat) ab+anti-PMN ab 'U, [21]
aGBM (rat) ab+anti-(32 ab 1J 'U, a
VCAM-1 lupus (mouse) 'U', mes. [36]
Symbols are: 'U' increased; 'I)', decreased; ', no change.
Abbreviations are: csGBM, anti-GBM nephritis; endo., endothelium; mes., mesangial; ab, antibody.
X. Wu, T.B. Issekutz, and J.B. Lefkowith, unpublished observations on accelerated anti-GBM nephritis
function blocking anti-cs4 antibody inhibits the influx of PMNs into
the glomerulus in anti-GBM nephritis with a modest reduction in
proteinuria (Table 1) [10, 211. However, little synergy was ob-
served when this antibody was concomitantly administered with
an anti-132 integrin antibody [21]. These latter data suggest that
the contribution of a4131 to PMN migration is either modest or
indirect (such as via an effect on the activation of the resident
mesangial M4s and/or their production of cytokines). In addition,
these data support the concept that a /31/132 integrin-independent
pathway for PMN migration into inflamed glomeruli exists, pos-
sibly involving the aforementioned interaction of PMNs and
platelets.
With respect to the counterreceptor for a4/31, vascular cell
adhesion molecule (VCAM)-1 expression has been observed to be
up-regulated acutely in the course of anti-GBM nephritis on
glomerular endothelium and within the mesangium (Table 1) [10].
Moreover, increased VCAM-1 expression is seen in murine lupus
nephritis within the glomerular mesangium (Table 1) [36].
Chemotactic agents
The motive force driving the emigration of leukocytes into a
focus of inflammation is the genesis of local chemoattractants. In
anti-GBM nephritis, the principal chemoattractant for PMNs is
complement (such as C5a) [5]. Complement probably also plays a
similar role in murine lupus nephritis [9, 37]. The chemotactic
signal generated by complement activation (which is relatively
brief) is most likely amplified temporally by the generation of a
(CXC) chemokines. In rat (which lacks an IL-8 homologue), the a
chemokines, CINC (cytokine-induced neutrophil chemoattrac-
tant) and MIP-2 (macrophage inflammatory protein-2), have both
been demonstrated to mediate PMN migration in anti-GBM
nephritis [29, 38], and may act in concert. Data using an anti-
human IL-8 antibody in anti-GBM nephritis in rabbit corroborate
the rat data [39]. The sources of a chemokines in the context of
nephritis are probably mesangial cells and invading inflammatory
cells [40]. Of additional note, the cytokines that produce increases
in the adhesion molecules ICAM-1 and VCAM-1 (that is, TNF-cs
and IL-113) also stimulate chemokine synthesis by mesangial cells
[40].
Monocyte/M4 migration in glomerulonephritis
Role of selectins
Very little is known about the role of selectins in mediating the
influx of monocytes/M41s into glomeruli. A potential role for
P-selectin was suggested by a recent study on anti-GBM nephritis
in rat (Table 2) [41]. In this study, P selectin was up-regulated on
glomerular endothelium, and a function blocking P-selectin anti-
body inhibited the local accumulation of monocytes/M4s and the
accompanying proteinuria [41]. Although there are no in vivo data
that address the role of L-selectin in monocyte/M4 migration, in
vitro L-selectin appears to mediate the adhesion of monocytes to
glomerular endothelial cells [15], At present, the role of E-selectin
in monocyte/M4. migration in immune-mediated glomerulone-
phritis is unknown.
Role of 132 integrins
The interaction of monocytes with glomerular mesangial cells in
vitro is qualitatively similar to that of PMNs [18]. As with PMNs,
much of this interaction is 132 integrin-dependent, although quan-
titatively there is a larger /32 integrin-independent component.
Also, ICAM-1 plays a relatively more important role when
mesangial cells are activated [18].
There are also in vivo data which substantiate the importance of
132 integrins/ICAM-1 to monocyte migration into inflamed gb-
meruli (Table 2). Both anti-aL and anti-ICAM-l antibodies have
been shown to markedly inhibit the influx of monocytes into
glomeruli during anti-GBM nephritis [42, 43]. These results,
however, are somewhat surprising in light of the aforementioned
in vitro data, and other studies that suggest that a substantial
component of monocyte adherence to endothelium in vitro and
monocyte/M4 migration in vivo is 132 integrin/ICAM-1-indepen-
dent [44—50]. In other studies, it was noted that neither anti-aM
nor anti-/32 integrin antibody administration inhibited the influx of
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monocytes/M4s during anti-GBM nephritis (Table 2) [20, 21].
Nonetheless, a possible role for 132 integrins in monocyte/M4
activation in situ was suggested by the latter study [21]. In this
study, anti-132 integrin antibody combined with anti-a4 antibody
inhibited the proteinuria that occurs concomitantly with the influx
of monocytes/Ms, although neither antibody had an effect on
monocyte/M4 migration or proteinuria alone [21].
It is possible that the differing results of the aforementioned
studies regarding the role of 132 integrins in monocyte/M4 migra-
tion were due to differences in the variant of anti-GBM nephritis
used. In the studies that indicated an important role for aLl32, the
model of anti-GBM nephritis depended on an autologous anti-
body response [42, 43]. In the aforementioned negative studies,
the anti-GBM model employed was a passive one (depending only
on administration of a heterologous anti-GBM antibody) [20, 21].
To address this possibility, we recently examined the effect of an
anti-j32 integrin antibody on monocyte/M4 migration in the
accelerated variant of anti-GBM nephritis, which depends on an
active antibody response to the inducing antibody. However, we
found a similar lack of efficacy of anti-/32 integrin antibody therapy
on monocyte/M4 migration in this model (X. Wu and J.B.
Lefkowith, unpublished observations; Table 2).
An additional noteworthy feature of the aforementioned stud-
ies on anti-aL therapy in glomerulonephritis was that administra-
tion of these antibodies prevented the histologic evolution of
crescents, which are felt to be derived from monocytes/M4s and
to be the harbinger of glomerulosclerosis [42, 43]. Furthermore, a
substantial effect could be seen without continuous therapy.
Combined anti-aL/ICAM-1 antibody therapy during the first two
weeks of autologous anti-GBM disease was as effective as contin-
uous therapy in terms of suppressing both glomerular hypercel-
lularity and crescent formation (as assessed at 5 weeks of disease)
[43]. Therapy during the terminal three weeks of this study,
however, was not as effective as the initial therapy and did not
prevent glomerular hypercellularity, but did block the formation
of glomerular crescents [43]. It remains to be determined, how-
ever, whether these effects are exclusively mediated by the disrup-
tion of M migration. In both of the aforementioned studies, a
possible contribution by PMNs to glomerular inflammation was
not conclusively ruled out, and as noted above, anti-ICAM-i
therapy would inhibit the migration of these cells into the
glomerulus. Recent work, in fact, suggests that PMNs have the
potential to make a substantial contribution to chronic glomerular
injury and scarring [8].
Role of /3 integrins
A potential contribution of a4131 to monocyte/M4 migration
was recently observed in anti-GBM nephritis. In this study, anti-a4
antibody administration partially inhibited the influx of M4s in
anti-GBM nephritis, but only when the preceding influx of PMNs
was abolished (by complement depletion; Table 2) [21]. The
residual influx of M4.s, however, could not be inhibited by
combined blockade with an anti-/32 integrin antibody. Neither
antibody alone (nor the combination) altered M4. influx if the
preceding influx of PMNs was not inhibited [21]. These data
suggest that there are 13 and 132 integrin-independent pathways
for monocyte/migration in anti-GBM nephritis.
In recent work, we have pursued this issue in the accelerated
variant of anti-GBM nephritis. Our results show that a combina-
tion of anti-a4 and -/32 integrin antibodies, but not anti-f32 integrin
antibody alone, substantially (although not completely) reduces
proteinuria and inhibits the influx of M4s (X. Wu, T.B. Issekutz,
and J.B. Lefkowith, unpublished observations; Table 2). The
efficacy of anti-a4 integrin antibody alone, the long term conse-
quences of combined antibody therapy, and the nature of /31/132
integrin-independent pathways for monocyte/migration into in-
flamed glomeruli remain to be determined.
Apropos to the above data on a4/31, the counterreceptor for this
integrin is also up-regulated in models of glomerular inflamma-
tion. As noted above, VCAM-1 expression is substantially up-
regulated in murine lupus corroborating the potentially important
role of this integrin in monocyte/M4 invasion (Table 2) [36].
Chemotactic agents
Although it is clear that monocyte/M migration can occur
independently of PMN migration and complement activation in
glomerulonephritis, the chemotactic agents that drive mono-
cyte/Mq' migration into inflamed glomeruli remain largely un-
known. A recent study, however, has shown that monocyte
chenioattractant protein-i (MCP-1, a /3 or CC chemokine) medi-
ates a component of monocyte/Mc1 influx in anti-GBM nephritis
[511. However, these data clearly show that other chemoattrac-
tants participate in this process, the nature of which remain to be
elucidated. Recent data also suggest that in situ proliferation of
M4s may be important to the kinetics of M4 trafficking in
immune-mediated glomerulonephritis [8, 52—54]. CSF-i may be
the mediator underlying this proliferative capacity of Ms [53].
Summary and future directions
In conclusion, the data to date have clarified many of the
molecular mechanisms underlying leukocyte migration into in-
flamed glomeruli and their in situ activation. It is nonetheless clear
that many aspects of leukocyte migration and activation in
immune-mediated glomerulonephritis remain uncertain, for ex-
ample, the contribution of selectins, the nature of PMN-platelet
interactions, and the role of other adhesion molecules [such as
platelet endothelial adhesion molecule (PECAM-1, CD31)]. Fur-
ther study is needed to clarify these issues and to gain insight into
how these data may be applied in a clinical context.
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